Ceprotin Europäische Union - Deutsch - EMA (European Medicines Agency)

ceprotin

takeda manufacturing austria ag - menschliches protein c - purpura fulminans; protein c deficiency - antithrombotische mittel - ceprotin is indicated for prophylaxis and treatment of  purpura fulminans  coumarin-induced skin necrosis and venous thrombotic events in patients with severe congenital protein c deficiency.